Research Article

Genetic Polymorphisms of IFNG, IFNGR1, and Androgen Receptor and Chronic Prostatitis/Chronic Pelvic Pain Syndrome in a Chinese Han Population

Table 4

Genetic models of SNPs and NIH-CPSI score in patients with CP/CPPS by using logistic regression.

SNPModelGenotypeCrude mean difference (95% CI)AICBICAdjusted mean difference (95% CI)aAICBIC

IFNG
rs2069718Codominant modelGA/AA1.62 (-1.08-4.31)0.49769.2780.21.66 (-1.04-4.36)0.48770.3784.1
GG/AA-0.59 (-7.68-6.51)-0.16 (-7.32-6.99)
Log-additive model-0.94 (-1.29-3.17)0.41768776.31.05 (-1.19-3.29)0.36768.9780
rs1861493Codominant modelGA/AA-1.21 (-3.64-1.22)0.57769.5780.6-1.29 (-3.72-1.15)0.56770.6784.4
GG/AA-1.36 (-4.72-2.01)-1.16 (-4.55-2.23)
Log-additive model--0.80 (-2.39-0.80)0.33767.7776-0.74 (-2.34-0.85)0.36768.9780
IFNGR1
rs10457655Codominant modelGA/GG0.98 (-1.71-3.67)0.1765.97770.99 (-1.72-3.69)0.13767.6781.5
AA/GG9.10 (0.58-17.62)8.62 (-0.09-17.34)
Log-additive model-1.95 (-0.41-4.30)0.11766774.31.86 (-0.51-4.23)0.13767.4778.4
rs35860242Codominant modelCT/CC-0.81 (-4.28-2.65)0.87770.4781.4-1.05 (-4.54-2.44)0.77771.2785.1
TT/CC-1.05 (-8.17-6.06)-1.67 (-8.88-5.54)
Log-additive model--0.67 (-3.22-1.87)0.6768.4776.7-0.95 (-3.54-1.65)0.48769.3780.3
rs3799488Codominant modelCT/TT-0.62 (-2.98-1.73)0.83770.3781.3-0.48 (-2.86-1.90)0.88771.5785.4
CC/TT0.54 (-4.29-5.36)0.54 (-4.29-5.37)
Log-additive model--0.19 (-2.03-1.65)0.84768.6776.9-0.11 (-1.96-1.73)0.9769.8780.8
rs7749390Codominant modelGA/GG0.99 (-1.53-3.51)0.727707811.07 (-1.46-3.60)0.7771784.9
AA/GG0.21 (-3.02-3.44)0.36 (-2.89-3.61)
Log-additive model-0.23 (-1.35-1.81)0.78768.6776.90.31 (-1.28-1.90)0.71769.6780.7
rs9376267Codominant modelCT/CC-1.21 (-3.74-1.32)0.56760.9771.9-1.16 (-3.70-1.37)0.54762.2776
TT/CC-1.61 (-5.03-1.81)-1.74 (-5.18-1.69)
Log-additive model--0.87 (-2.53-0.79)0.3759767.3-0.92 (-2.59-0.74)0.28760.2771.3
rs9376268Codominant modelGA/GG-1.28 (-3.74-1.18)0.54760.8771.9-1.27 (-3.73-1.19)0.52762.1775.9
AA/GG-1.46 (-4.95-2.02)-1.66 (-5.19-1.86)
Log-additive model--0.85 (-2.51-0.81)0.32759767.3-0.93 (-2.60-0.74)0.28760.2771.3
AR
rs138464995TT/CC1.81 (-3.14-6.76)0.47697.97061.65 (-3.35-6.66)0.52699.6710.4
rs142203174CC/AA-1.50 (-5.18-2.18)0.43768776.3-1.26 (-4.99-2.46)0.51769.3780.4
rs192195540CC/GG0.97 (-1.87-3.80)0.51759.6767.90.92 (-1.92-3.76)0.53761772.1
rs139374285TT/CC-1.53 (-7.06-4.00)0.59768.3776.7-1.56 (-7.09-3.97)0.58769.5780.5
rs72627670TT/CC0.02 (-3.21-3.25)0.99760.1768.40.07 (-3.17-3.31)0.97761.4772.5
rs144488434TT/CC3.69 (-1.80-9.19)0.19766.9775.23.55 (-1.96-9.06)0.21768.2779.2
rs143099096AA/CC2.57 (-3.57-8.72)0.41768776.32.36 (-3.81-8.53)0.45769.2780.3
rs78445514CC/TT-0.50 (-3.53-2.53)0.75768.5776.8-0.74 (-3.80-2.33)0.64769.5780.6
rs141340859CC/TT1.98 (-2.17-6.13)0.35759.2767.52.02 (-2.14-6.17)0.34760.5771.6
rs5965429GG/AA1.51 (-0.98-4.01)0.24744.6752.91.51 (-0.99-4.01)0.24745.9756.9

AIC: Akaike’s Information Criterion; BIC: Bayesian Information Criterion; CP/CPPS, chronic prostatitis/chronic pelvic pain syndrome; MD: mean difference; NIH-CPSI: National Institutes of Health Chronic Prostatitis Symptom Index; OR: odds ratio; SNPs: single nucleotide polymorphisms. aAdjusted by age.